首页|beta-1,4-Galactosyltransferase-V colorectal cancer biomarker immunosensor with label-free electrochemical detection
beta-1,4-Galactosyltransferase-V colorectal cancer biomarker immunosensor with label-free electrochemical detection
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NSTL
Elsevier
beta-1,4-Galactosyltransferase-V (beta-1,4-GalT-V) is a membrane-bound glycoprotein with glycosyltransferase enzyme activity that synthesizes lactosylceramide and glycosylates high-branched N-glycans in the Golgi apparatus. Colorectal cancer (CRC) tumor cells have shown to overexpress these biomolecules concerning normal cells, releasing them into the body fluids. Thus, their detection has been suggested as a diagnosis/prognosis CRC biomarker. We report the first electrochemical immunosensor for the detection of such a novel beta-1,4-GalT-V CRC biomarker. The label-free electrochemical immunosensor covalently coupled an anti-beta-1,4-GalT-V antibody at a mixed self-assembled monolayer-coated screen-printed gold electrode (SPAuE) surface. This functionalized platform captured the beta-1,4-GalT-V glycoprotein from human serum samples with high specificity, which response monitored by electrochemical impedance spectroscopy (EIS) was protein concentration-dependent. The resultant electrochemical immunosensor showed a linear dynamic range from 5 to 150 pM, with a sensitivity of 14 Omega pM(-1) and a limit of detection of 7 pM, of clinical relevance. This outstanding performance makes it great potential for including it in a biomarker signature for the early diagnosis/prognosis of CRC.
NSTL
Elsevier
